Leg patch may ease bladder troubles after prostate surgery
NCT ID NCT07710794
First seen Jul 17, 2026 · Last updated Jul 17, 2026
Summary
This study tests whether a small, wearable patch that stimulates a nerve in the leg can help men who still have bladder symptoms after prostate surgery. Participants will either receive behavioral therapy alone or behavioral therapy plus the patch for 12 weeks. The goal is to see if the patch reduces frequent urination, urgency, and nighttime bathroom trips.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- a nerve-stimulating patch worn on the leg (transcutaneous tibial nerve stimulation)
- What this could lead to
- If effective, this patch could offer a non-invasive, at-home option to reduce frequent urination and urgency after prostate surgery.
- What could go wrong
- This is a small, early-stage study with only 70 participants, so results may not apply to everyone. The patch may not provide additional benefit over behavioral therapy alone.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 70 people
The number the study aims to enrol. It can still change while the study runs.
- Expected to start
-
Jun 2026
An estimate. Start dates often move.
- Expected to finish
-
Jan 2027
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
50 to 80 years
- Sex
-
Male participants only
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * 1\. Male, aged 50 to 80 years. 2. Diagnosis of benign prostatic hyperplasia (BPH) confirmed by IPSS, imaging, PSA, pathology, or other relevant assessments. 3\. Previous treatment with transurethral laser enucleation of the prostate for BPH. 4\. Persistent overactive bladder symptoms one month after surgery, defined as an average of ≥8 voids per 24 hours documented on a 72-hour voiding diary. 5\. Not currently using, or having discontinued at least 14 days prior to enrollment, all related medications (e.g., β3-adrenoceptor agonists, non-selective β-adrenoceptor agonists, or anticholinergics). 6\. Medically stable and not requiring hospitalization. 7. Voluntary participation in this clinical study, with written informed consent signed by the participant before study initiation. Exclusion Criteria: * 1\. History of urinary tract infection, urinary tract malformation, obstruction, anatomical abnormality, or neurological disorder. 2\. Known allergy to electrode gel or skin breakdown that precludes the use of surface electrodes. 3\. Presence of psychiatric or cognitive impairment that renders the patient unable to cooperate with the study procedures. 4\. Any serious comorbidity or condition that may hinder the patient's participation or increase the risk associated with surgical procedures. 5\. Participation in another clinical trial within 3 months prior to screening that could potentially affect the results of this study. 6\. Other conditions deemed unsuitable for participation by the investigator.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BPH (benign prostatic hyperplasia) are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
Qilu Hospital of Shandong University
Jinan, Shangdong, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a Three-Hour online class help families manage bladder and bowel issues in duchenne muscular dystrophy?
- Can a maca root pill calm Men's urinary woes?
- Two prostate pills instead of one: can doubling up on alpha blockers clear urine retention?
- Can a gel stop bleeding after prostate surgery and send men home the same day?
- Can a smarter needle angle make prostate relief safer and easier?
- Can a Needle-Free prostate treatment match implant surgery?